Garber Alan M — SEC Form 4 filings

SEC reporting owner CIK 1312907. 6 Form 4 filings on record with FilingPulse; latest filed 2026-07-17.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-03-25 to 2026-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
EXELIXIS, INC. (EXEL)Director11 leg · 19,205 sh · $461,1122
VERTEX PHARMACEUTICALS INC / MA (VRTX)Director57

Form 4 filings — Garber Alan M

FiledFormIssuerReported transactionsSource
2026-07-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 31.56 (derivative) @ $475.28EDGAR
2026-05-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 472 @ $0 · Grant/award (A): 1,433 (derivative) @ $0EDGAR
2026-04-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 33.90 (derivative) @ $442.50EDGAR
2025-05-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 398 @ $0 · Grant/award (A): 1,199 (derivative) @ $0EDGAR
2024-05-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 3,142 (derivative) @ $0EDGAR
2024-03-254EXELIXIS, INC. (EXEL)Option exercise (M): 23,491 @ $19.57 · Sale (S): 19,205 @ $24.01 · Option exercise (M): 23,491 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1312907 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →